Stay updated with breaking news from Plus therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus Therapeutics To Host Investor Call To Discuss Leptomeningeal Cancer Related Acquisition And Topline Clinical Trial Data From The FORESEE Trial menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Plus now has $23 million in active awards support for the Company's targeted radiotherapeutic pipeline Funding for pediatric brain cancer treatment is expected to begin in Q3 2024, pending contract finalization ....
The addition of both Dr. Brenner and Dr. Blouw substantially expands Plus internal expertise in key areas Dr. Brenner will maintain his academic commitments but will greatly contribute to Plus’ scientific and clinical efforts to develop targeted radiotherapeutics for central nervous system (CNS) cancers Dr. Blouw is an expert in CNS tumor biology and in the diagnosis of neoplasms of the cerebrospinal fluid AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) Plus Therapeutics, Inc. (Nasdaq: PSTV) ( ....
Phase I Trial: AZD1390 & Radiotherapy Effective, Safe for Glioblastoma miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.